PROTEOMICS INTERNATIONAL LAB

Proteomics Lab’s 4.35 % rally is a fleeting blip: the company’s low liquidity, flat valuation and opaque R&D pipeline make it a high‑risk speculative play with limited upside potential.

Proteomics International Laboratories flat at AUD 0.12 as it heads to its AGM on 20 Nov 2026—reviewing 2026 results, CEO remuneration, and future growth plans.

Proteomics International Laboratories (PIQ.AX) – see latest trading, market cap, 52‑week highs/lows, and key peer performance, plus insights on peptide drug R&D.